Electrochemotherapy and Ablative Therapies in Non-melanoma Skin Cancer

N O'Donoghue; D Mowatt; A J Sykes

doi:10.1016/j.clon.2019.08.010

Electrochemotherapy and Ablative Therapies in Non-melanoma Skin Cancer

Clin Oncol (R Coll Radiol). 2019 Nov;31(11):e1-e9. doi: 10.1016/j.clon.2019.08.010. Epub 2019 Sep 19.

Authors

N O'Donoghue¹, D Mowatt², A J Sykes³

Affiliations

¹ Salford Royal NHS Foundation Trust Hospital, Salford, UK.
² The Christie NHS Foundation Trust Hospital, Manchester, UK.
³ The Christie NHS Foundation Trust Hospital, Manchester, UK. Electronic address: andrew.sykes@christie.nhs.uk.

PMID: 31543301
DOI: 10.1016/j.clon.2019.08.010

Abstract

Although surgery and radiotherapy remain the most commonly used treatments for non-melanoma skin cancer, there are a variety of alternatives. Here we discuss the use of electrochemotherapy and ablative treatments and examine the evidence for their effectiveness against a number of non-melanoma skin cancers.

Keywords: Ablative; electrochemotherapy; keratinocyte tumours; non-melanoma; skin cancer.

Publication types

Review

MeSH terms

Drug Combinations
Electrochemotherapy / methods*
Estradiol / analogs & derivatives*
Estradiol / pharmacology
Estradiol / therapeutic use
Humans
Norethindrone / pharmacology
Norethindrone / therapeutic use*
Skin Neoplasms / therapy*
Testosterone / analogs & derivatives*
Testosterone / pharmacology
Testosterone / therapeutic use

Substances

Drug Combinations
estradiol, norethisterone, testosterone drug combination
Testosterone
Estradiol
Norethindrone